Vulvovaginal infections have increased dramatically in terms of its severity and incidence recently. Dermatophytes are most common fungal infection globally and according to WHO the prevalence is 20-25%. About75% women show a vulvovaginal candida episode through their life time and 5-10% will experience recurrence; more than 4 episodes per year. Hence the vulvar fungal infection if left untreated it may increase the risk of long term complications due to ascending infections. Fungal infection of vulva is not a life threatening condition but itching from it can be  very uncomfortable and there will be significant decrease in quality of life. Yoni kandu as an individual disease is mentioned in BhaishajyaRatnavali Yonikandu Chikitsa Prakarana as a Kaphaja vyadhi. In all Samhitas Yonikandu is mentioned as a symptom of Kaphaja Yoni Vyapat. If it is left untreated it may progress to other diseases like Acarana, Atyananda, Aticarana and Karnini where Yonikandu coexists with other symptoms making  the treatment more complicated.While assessing the Ayurvedic literatures Acharya Susruta in uttaratantra has specifically mentioned a combination for external application in Yonikandu. And hence through this study an attempt will be made to develop the combination into a more user friendly cream form(Brihati phaladi cream) and a combination therapy with internal medication(Aragwadaha twak kashaya) will be studied on vulvar itch from fungal infections. 30 patients in the age group 16-50yrs complaining of vulvar itch with or without discolouration of skin will be selected  from the OPD and IPD of Amrita School of Ayurveda, to be screened by taking skin scrapings of the affected area followed by KOH wet mount test to diagnose vulvar fungal infection. If the diagnosis is confirmed treatment will be done on OP basis by providing medicines, Aragwadha twak kashaya choorna which has to be prepared as decoction [1 pala(48gm) powdered drugs is to be boiled in 16 parts of water(768ml) and reduced to 1/8 parts(96ml)] for internal administration. Brihati phaladi cream has to be applied in the affected area twice daily. Medicines will have to be continued for 21 days. Assessment will be done for itching(yoni kandu) on day 0, day 11 and day 22^nd  by 5 D Itch scale and Quality of life of patients will be assessed using Dermatology Life Quality Index(DLQI)  on day 0 and day 22^nd . Followup will be done on 30^th day after treatment.

30 patients recruited to the study and was successfully completed documenting the effect of trial drug in the condition of Yoni kandu. The study was completed where in null hypothesis was rejected.